Visual outcomes of patients
| Best eye (SD) | Worse eye (SD) | ||
| Presentation | logMAR 0.14 (0.26) | logMAR 0.60 (0.73) | |
| Start of biologic | logMAR 0.19 (0.34) | logMAR 0.52 (0.68) | |
| Latest review | logMAR 0.16 (0.32) | logMAR 0.43 (0.72) | Mean: 4.46 years Median: 4.40 years |
| Improve by ≥2 lines (%) | Retained vision (%) | Worsen by ≥2 lines (%) | |
| Presentation to start of biologic (n=89) | 17 eyes (19.1%)* | 51 eyes (57.3%)* | 21 eyes (23.6%)* |
| Start of biologic to latest review (n=89) | 21 eyes (23.6%)* | 63 eyes (70.8%)* | 5 eyes (5.6%)* |
*The proportion of patients on the improving, retaining or worsening vision is different between presentation to start of biologic and start of biologic to latest review (χ2=11.5, critical value=5.99).
logMAR, logarithm of the minimum angle of resolution.